Bude-formoterol 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FATYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,349
Award facts
- Contract value 100% obligated
- $11,348.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,348.64 to AmerisourceBergen Drug Corp for Budesonide-Formoterol on January 18, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Budesonide-Formoterol—a bronchodilator medication used in respiratory treatment—represents a routine task order fulfillment under this strategic contract vehicle that also serves the Defense Health Agency and U.S. Coast Guard healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FATYL?
SPE2DR26FATYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 18, 2026.
How much is contract SPE2DR26FATYL worth?
The government has obligated $11,349 on SPE2DR26FATYL.
Is contract SPE2DR26FATYL an order under another contract?
Yes. SPE2DR26FATYL is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATYL competed?
The extent of competition for SPE2DR26FATYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award